Learn more about the technologies that can help automate your processes earlier and achieve therapeutic firsts for the patients who need them most.
Quantum is an automated platform designed to simplify the open, labor-intensive tasks associated with manual cell culture.Learn More View Video
Finia helps to automate downstream processing in your final formulation process.
Under development. Final features may vary in the released product.
Spectra Optia is the industry-leading therapeutic apheresis, cell therapy and cell collection platform, designed to enhance versatility, performance and patient comfort and safety.Learn More Request Info
When monocytes or lymphocytes are on your radar, Elutra should be as well.Learn More View Video
*Customers are responsible for validating the use of Quantum to expand cells for their intended therapy.
†Customers are responsible for validating the use of Elutra to separate cells for their intended therapy.
Miami: 22 to 25 January 2019
London: 25 to 27 February 2019
New York City: 2 to 4 April 2019
Barcelona: 23 to 25 April 2019
Washington, D.C.: 29 April to 2 May 2019
Melbourne: 29 May to 1 June 2019
Shanghai: 18 to 20 June 2019
From webinars to white papers and publications, learn more about Quantum in our comprehensive technical resource library. It covers a range of cell types and areas of interest so you can understand the full capabilities of the Quantum system.Learn More
Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, believes in the potential of blood and cells to do even more for patients than they do today. Terumo BCT’s Cell Therapy Technologies business enables researchers, developers and manufacturers to create next-generation cell and gene therapies.